FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $8,585,000 | -41.0% | 2,577,982 | -46.2% | 0.12% | -55.4% |
| Q3 2019 | $14,558,000 | +17.7% | 4,788,896 | -7.8% | 0.28% | +44.5% |
| Q2 2019 | $12,365,000 | -36.5% | 5,195,330 | 0.0% | 0.19% | -36.8% |
| Q1 2019 | $19,482,000 | +4.5% | 5,195,330 | 0.0% | 0.30% | -12.5% |
| Q4 2018 | $18,651,000 | -37.3% | 5,195,330 | 0.0% | 0.34% | -3.9% |
| Q3 2018 | $29,769,000 | +47.1% | 5,195,330 | +28.6% | 0.36% | +49.0% |
| Q2 2018 | $20,240,000 | +215.6% | 4,040,000 | +223.2% | 0.24% | +201.2% |
| Q1 2018 | $6,413,000 | – | 1,250,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 4,781,708 | $24,530,000,000 | 3.64% |
| Opaleye Management Inc. | 950,000 | $4,873,000 | 1.39% |
| DSC Advisors, L.P. | 1,187,604 | $6,092,000 | 1.28% |
| DAFNA Capital Management LLC | 335,500 | $1,721,000 | 0.84% |
| Vivo Capital, LLC | 855,000 | $4,386,000 | 0.62% |
| Stonepine Capital Management, LLC | 129,756 | $666,000 | 0.36% |
| Eversept Partners, LP | 107,500 | $551,475 | 0.26% |
| Tekla Capital Management LLC | 930,398 | $4,773,000 | 0.19% |
| Perceptive Advisors | 1,117,324 | $5,732,000 | 0.16% |
| Crestline Management, LP | 217,670 | $1,117,000 | 0.14% |